Advancing Respiratory Medicine
The MediPines AGM100® provides fast, accurate, and non-invasive assessments of pulmonary gas exchange to improve diagnostic decisions.
Global Respiratory Disease
We are the market leader in non-invasive, rapid assessment of pulmonary gas exchange.
Improve Patient Outcomes
Achieve over 90% patient compliance with our breathing circuit.
PaO2 accuracy of over 95% compared to traditional ABG.
No labs, blood draw or complex set up. No calibration required.
In less than 2 minutes, we provide 12 cardiopulmonary diagnostic parameters
Improve diagnostic decisions across the continuum of care. From the emergency room to out-patient clinics, our device has helped patients receive faster, more accurate diagnosis.
How the AGM100 Works
Gas exchange measurement in under 90 seconds
Award winning medical device, trusted by doctors and patients
AGM100 selected by WHO
“Innovative technologies are accelerating access to healthcare everywhere, we must ensure that they (innovative technologies) are readily available in all health facilities, fairly priced and quality-assured”
- WH0 Assistant Director General
Medical Design Award
AGM100 receives special designation
MediPines AGM100® device has been awarded the prestigious MDEA Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence Awards
News and Updates
Our Latest Publications
Read about the latest publications and learn the science behind the AGM100.